Northport Resident and Harborfields H.S. Physical Education Teacher Bryan Proctor Raises Awareness for Alzheimer’s Disease at the 8th Annual Distant Memories Swim
Mr. Proctor and his teammates will start out at Asharoken Beach and swim across the bay to Knollwood Beach — a distance of approximately 3.5 nautical miles (more than 4 miles). The swim will also help raise funds for Alzheimer’s Association Long Island through sponsorships and corporate donors. The goal is to raise $15,000 to help support services and programs for Long Island families coping with the challenges of Alzheimer’s disease.
This year, Mr. Proctor and his team will dedicate the swim in memory and honor of Harold Charles “Hal” Daly. Mr. Daly was a lifeguard for 40 years. He served in the U.S. Navy as a medical corpsman reservist and also worked for the United States Postal Service. Family members and friends remember Mr. Daly for his juggling and balancing acts that would amaze everyone. In his later years, Mr. Daly was diagnosed with Alzheimer’s disease. He died in 2003.
Currently, 5.4 million people in this country have Alzheimer’s disease and more than 200,000 individuals under the age of 65 have a diagnosis of Alzheimer’s disease. By the middle of this century, it is estimated that approximately 14-16 million people will have a diagnosis of Alzheimer’s disease; 1 out of 8 baby boomers is at risk. This issue is very close to Mr. Proctor, as his grandfather and aunt passed away from Alzheimer’s disease.
“Bryan is a champion for those with a diagnosis of Alzheimer’s disease. He is a role model for the youth of our country,” states Mary Ann Malack-Ragona, Executive Director/Chief Executive Officer for Alzheimer’s Association Long Island. “He has continuously expressed the sentiment that he wants to raise awareness about this deadly disease and help families who live on Long Island.”
“It is my hope that substantial funds will be raised to assist Alzheimer’s Association Long Island in providing for people with dementia and other related disorders,” Mr. Proctor said.
The Alzheimer’s Association is the nation’s leading voluntary health organization dedicated to supporting families and caregivers by providing vital programs and services in local communities nationwide. The Association is the largest private funder of Alzheimer’s research, having committed more than $200 million to research. A minimum of 75% of every dollar raised by the Alzheimer’s Association funds programs to promote research, find effective treatments, and improve the lives of those affected by Alzheimer’s.
For more information about this event or the Alzheimer’s Association, please contact Mary Ann Malack-Ragona at (631) 820-8068. To sponsor Mr. Proctor and/or his teammates, please visit www.memoryswim.org. Donations may also be sent to: Alzheimer’s Association Long Island, 3281 Veterans Memorial Highway, Suite E-13, Ronkonkoma, NY 11779.
Director of Public Relations
156 North Ocean Avenue
Patchogue, NY 11772
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Northport Resident and Harborfields H.S. Physical Education Teacher Bryan Proctor Raises Awareness for Alzheimer’s Disease at the 8th Annual Distant Memories Swim here
News-ID: 183701 • Views: 1599
More Releases from Alzheimer's Association Long Island
Alzheimer’s Association Long Island Hosts Second East End Walk to End Alzheime …
Following the success of this summer’s East End Walk to End Alzheimer’s in Riverhead, Alzheimer’s Association Long Island will have its second East End Walk to End Alzheimer’s/Fall Festival on October 20 at the intersection of Main Street and the Village Green (near the gazebo) in Westhampton Beach. Registration begins at 9 a.m., followed by the opening ceremony at 10 a.m. and the Walk at 11 a.m. The opening ceremony will
East End Walk to End Alzheimer’s to be Held August 25
Alzheimer’s Association Long Island is inviting Eastern Long Island residents to unite in a movement to reclaim the future for millions by participating in the East End Walk to End Alzheimer’s on August 25. This year’s walk will begin at Downtown Riverhead’s Grangebel Park on Peconic Avenue and end at the Long Island Aquarium & Exhibition Center (formerly known as Atlantis Marine World), located at 431 Main Street in Riverhead.
Alzheimer’s Association Long Island Welcomes New Care Consultant Amy Oster
Alzheimer’s Association Long Island has announced that Amy Oster will join the organization as its Care Consultant. In her new role, Ms. Oster will regularly meet with families of those suffering from Alzheimer’s disease to develop a long-term care plan and discuss available programs and resources. Ms. Oster has been successful in facilitating the support group for caregivers, which has greatly increased in size under her leadership. Before joining Alzheimer’s Association
MEDIA ADVISORY 4/3 "It Starts with Sylvan" Donates $1,000 towards 2012 Walk to E …
Who: Mary Ann Malack-Ragona, Executive Director/Chief Executive Officer, Alzheimer’s Association Long Island Patty Gorman, Team Captain, It Starts With Sylvan
More Releases for Alzheimer’s
Global Alzheimer’s Drugs Market Analysis (2020-2025)
Global Info Research offers a latest published report on Alzheimer’s Drugs Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Alzheimer’s Drugs Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/reports/516177/alzheimer%25E2%2580%2599s-drugs Market
Global Alzheimer’s disease, Dementia and Ageing Awareness
Lexis brings in a new spin on conferences by presenting the latest scientific improvements in the fields of Neurology and Neuroscience. Zurich is all set for an amazing event as LEXIS proudly presents the “Global Alzheimers, Dementia and Ageing Awareness” slated on July 17-18, 2019 at Zurich, Switzerland. The theme of the conference is “Global Voice and Awareness on Alzheimers Disease and Dementia Care”. Avenue Roger VAndendriessche, 18 at 1150 BRUSSELS Avenue
Global Alzheimer’s disease (AD) Market to 2024
Market Overview, Key in-line Products, Market Share Distribution, Competitive Dynamics, Regulatory Outlook, Pipeline Development, Growth Catalysts & Challenges, Leading Market & R&D Trends, Partnership & Deals Analyses, Global Sales forecast of in-line and pipeline products, Fast Growing Private Companies, Management Perspectives, Commentaries, Market Outlook & Summary Conclusions Global Alzheimer’s disease (AD) market was valued at $3.1bn in 2015 and is forecast to grow at a modest 5.3% CAGR between 2015
Europe Alzheimer’s Drug Pipeline Analysis
The incidence of Alzheimer’s disease has been on a rise in Europe in recent years and it most likely to continue rising in the near future. It has been observed that close to 50% of dependency of aged people in Europe is attributed for by Alzheimer’s disease. The rapid growth in the prevalence of Alzheimer's disease over the next few decades in Europe is expected to result in immense pressure
Alzheimer’s Disease Therapeutics Market Forecast – (2016-2020)
Alzheimer’s Disease Therapeutics in Major Developed Markets to 2021 - Aging Population and Improved Disease Understanding Increase Demand for Disease Modifying Agents Summary of the report: Alzheimer's Disease (AD) is an irreversible, progressive neurodegenerative disease, characterized by cognitive impairment, memory loss and functional decline. Symptoms typically begin to first appear in patients in their mid-sixties, with symptoms appearing in varying stages. The pathological features of AD comprise histopathological changes within the brain.
Otava Alzheimer’s Disease Targeted Libraries
Alzheimer’s disease (AD) is a devastating and always fatal neurodegenerative disorder characterized by progressive impairment of cognitive function and emotional disturbances. Currently, more than 25 million people worldwide live with AD. But there is no cure for AD and no treatment to reverse its progression, there are medicines available that can help treat symptoms in some people with this disease. Intensive scientific research around the world brings us closer to